Abstract
The close anatomical relationship of the urogenital system is a significant, and sometimes limiting, factor in oncogynecology. Here, we highlight the modalities used to treat gynecological cancer and discuss the most common urological adverse effects related to these interventions.
Knowledge of side effects, as well as methods of prevention, is fundamental if we are to preserve quality of life. Treatment of gynecological cancer is based on cooperation between members of the multidisciplinary team.
From this point-of-view, combination of two radical modalities (mainly surgery and radiotherapy) remains problematic. However, the patient's prognosis, and plans for other possible oncological therapies, play an essential role in management of urological adverse effects related to cancer treatment.